ALPHA | ALPHA IVF GROUP BERHAD [NS]
0.305 (-1.61%)
T-O (am): 0.000 (08:59:00)
T-O (pm): 0.305 (14:29:00)
Last updated: 16:52
ALPHA [NS] Fundamental Trend
FCON: | Sharpe Ratio: | LTS:
ALPHA [NS] Quarter Reports
Customize
Select columns required and click "Update" to save your preferences
| Ann. Date | Qtr. Date | Q | FYE | Revenue [M] | PBT [M] | NP [M] | NPM | DPS | EPS | R. QoQ | R. YoY | E. QoQ | E. YoY | TTM EPS |
Adj. [M] |
NP [M] (adj) |
NPM (adj) |
EPS (adj) |
E. QoQ (adj) |
E. YoY (adj) |
TTM EPS (adj) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28 Oct 25 | Q1 Aug 25 | 1 | 31 May 26 | 52.09 | 20.98 | 15.28 | 29.3% | 0.50 | 0.31 | 4.2% | 21.2% | 4.9% | 6.2% | ||||||||
| 28 Jul 25 | Q4 May 25 | 4 | 31 May 25 | 50.01 | 21.37 | 16.07 | 32.1% | 0.00 | 0.33 | 23.2% | 7.0% | 35.0% | 14.7% | ||||||||
| 22 Apr 25 | Q3 Feb 25 | 3 | 31 May 25 | 40.60 | 15.58 | 11.90 | 29.3% | 0.50 | 0.24 | 6.1% | 0.3% | 21.2% | 12.4% | ||||||||
| 21 Jan 25 | Q2 Nov 24 | 2 | 31 May 25 | 43.24 | 20.19 | 15.10 | 34.9% | 0.00 | 0.31 | 0.6% | 12.2% | 5.0% | 23.6% | ||||||||
| 21 Oct 24 | Q1 Aug 24 | 1 | 31 May 25 | 42.99 | 19.00 | 14.38 | 33.5% | 0.45 | 0.30 | 8.0% | 2.7% | ||||||||||
| 17 Jul 24 | Q4 May 24 | 4 | 31 May 24 | 46.74 | 19.42 | 14.01 | 30.0% | 0.00 | 0.29 | 14.8% | 3.1% | ||||||||||
| 16 Apr 24 | Q3 Feb 24 | 3 | 31 May 24 | 40.70 | 18.01 | 13.59 | 33.4% | 0.49 | 0.30 | 5.6% | 11.2% | ||||||||||
| 18 Mar 24 | Q2 Nov 23 | 2 | 31 May 24 | 38.54 | 16.64 | 12.21 | 31.7% | 0.21 | 0.27 |
ALPHA [NS] Historical Dividends
ALPHA [NS] Financial Ratios
| EPS | 1.2 sen |
| Trailing PE (Sector Median: 26.0) | 25.4 |
| PEG | 18.81 |
| Altman Z | 2.4 |
| Beaver | 0.204 |
| Current Ratio | 5.64 |
| Debt-Equity (DE) Ratio | 0.29 |
| FCF Yield | 0.62 % |
| Revenue QoQ | 4.18 % |
| Revenue YoY | 21.17% |
| Profit QoQ | -4.9 % |
| Profit YoY | 6.25 % |
| Profit Margin (Sector Median: 7.5) | 31.38 % |
| ROE (ROIC: 30.92) | 30.92 % |
| Dividend Per Share (DPS) | 1.0 sen |
| Dividend Yield (DY) | 3.28 % |
ALPHA [NS] Adjusted Financial Ratios
Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports
| EPS | |
| Trailing PE (Sector Median: 26.0) | |
| Profit QoQ | |
| Profit YoY | |
| Profit Margin (Sector Median: 7.5) | |
| ROE (ROIC: 31.25) | |
| Altman Z |
ALPHA [NS] Fair Value
Weighted Average Fair Value:
| Discounted Cash Flow (DCF) 5% Growth | |
| Discounted Cash Flow (DCF) 10% Growth | |
| Relative Valuation | |
| Average Analysts FV based on 1 rating(s) |
| Graham Formula | |
| Graham Number | |
| Net Tangible Asset (NTA) | 0.04 | Consistent QR FV |
Advanced Calculators
Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.
| Forward PE FV Calculator | |
| Latest Profit (adjusted) [M] | 15.45 |
| Expected Profit (Next QR) [M] | |
| Expected Profit (After QR above) [M] | |
| Expected Profit (After QR above) [M] | |
| Estimated Fair Value |
| Growth/Risk Fair Value Calculator | |
| Expected growth (%) | |
| Estimated downside / risk (%) | |
| Estimated New DCF Fair Value |
| Contract/Award Contribution Calculator | |
| Contract/Award Value (in Million) | |
| Estimated Contribution to Stock Price | |
| Estimated New DCF Fair Value |
| Profit-Based Calculator | |
| Expected Profit (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Revenue-Based Calculator | |
| Expected Revenue (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Market Pricing | |
| Expected Profit (M) | 0 |
| Expected Revenue (M) | 0 |
| Expected Growth (%) | 0 |
ALPHA [NS] Directors Share Purchases (Beta)
No transaction in the last 2 months.
ALPHA [NS] Summary
Market Cap: 1482 M.
Market Cap Class: Middlers
Number of Shares: 4860 M.
Adjusted Float: 0%.
Alpha IVF Group Berhad is a leading provider of assisted reproductive services (ARS). The company specializes in advanced fertility treatments such as in-vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and preimplantation genetic testing (PGT). Alpha IVF also offers a range of supporting medical services, including andrology, embryology, and cryopreservation, catering to individuals and couples facing fertility challenges. With state-of-the-art laboratory facilities and a team of experienced medical specialists, the group emphasizes innovative and patient-centered care. Committed to excellence in reproductive healthcare, Alpha IVF serves a diverse clientele, locally and internationally, with a focus on achieving positive patient outcomes and advancing fertility science. Alpha IVF was incorporated in 2021 and headquartered in Petaling Jaya, Selangor, Malaysia.
Sectors: Healthcare, Health Care Providers, Penny Stocks
Code: 0303
Website: http://www.alphaivfgroup.com
Related Links: Bursa | Annual Report | Announcement
Warrant Info:
No warrants listed
ALPHA [NS] Top Shareholdings
| Shareholder | % | Value (M) |
|---|---|---|
| Dato' Dr Lee Soon Soo | 35.11% | 520.48 |
| Ace Specialists Sdn Bhd | 9.22% | 136.7 |
| Dr Ng Peng Wah | 8.33% | 123.46 |
| Madam Sia Bee Keng | 0.01% | 0.21 |
Frequently Asked Questions
ALPHA IVF GROUP BERHAD Latest News
ALPHA Insights+
Some features of iSaham Insights are exclusively available to iSaham Pro clients.
Learn More about iSaham ProResearch House Target Price
Average Target Price: N/A
Entitlements
(Bonus Issue, Share Split or Share consolidation for the past 3 years)
| Ex-Date | Category | Entitlements |
|---|---|---|
| No entitlements detected |
Private Placements
(Fund raising via private placement shares for the past 3 years)
| Date | Stage | Purpose | Issue Price |
|---|---|---|---|
| No Private Placements detected |